Copyright
©The Author(s) 2019.
World J Clin Cases. Sep 6, 2019; 7(17): 2487-2504
Published online Sep 6, 2019. doi: 10.12998/wjcc.v7.i17.2487
Published online Sep 6, 2019. doi: 10.12998/wjcc.v7.i17.2487
Variables | Range or number |
Procedures | 100 |
Patients | 92 |
Interventional access | |
Percutaneous | 81 |
Open | 1 |
Laparoscopic | 1 |
Transosseous | 1 |
Not available | 16 |
Guidance modality | |
US | 31 |
CT | 20 |
MRI | 1 |
US and CT | 19 |
Not available | 29 |
Primary treatment failure | 3 |
Secondary treatment failure | 1 |
Recurrence | 1 |
Disease-specific mortality | 0 |
Overall renal allograft loss | 5 |
Peri-operative complication | 11 |
Urinary leakage | 1 |
Post-infarction syndrome | 1 |
Hematoma | 2 |
Infection of the ablation site | 2 |
Leg pain due to nerve injury | 4 |
Leg pain due to muscle injury | 1 |
Follow-up (mo) | 1-81 |
- Citation: Favi E, Raison N, Ambrogi F, Delbue S, Clementi MC, Lamperti L, Perego M, Bischeri M, Ferraresso M. Systematic review of ablative therapy for the treatment of renal allograft neoplasms. World J Clin Cases 2019; 7(17): 2487-2504
- URL: https://www.wjgnet.com/2307-8960/full/v7/i17/2487.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i17.2487